Risk and benefit of direct oral anticoagulants or PAR-1 antagonists in addition to antiplatelet therapy in patients with acute coronary syndrome
Keywords: Acute coronary syndrome; Direct Xa inhibitors; Direct thrombin inhibitors; PAR-1 antagonist;